AzTrials
AzTrials

Diabetic Foot UlcerNCT04310137

Self-directed Versus Therapist-directed Re-loading on Incidence of Ulcer Recurrence

A study testing Therapist-Directed Re-loading in people with Diabetic Foot Ulcer, run by Mercer University at 1 site in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study is designed to evaluate if how people are told to return to walking after a skin injury affects whether or not they develop new (recurrence) skin breakdown on their feet. The people in this study will have diabetes and have a recently closed foot ulcer. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Diabetic Foot Ulcer
What is being tested?
Therapist-Directed Re-loading
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteUnited States
Study dates
1 May 2021to Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • With or without peripheral neuropathy
  • Able to safely exercise
  • Have a recently closed plantar ulceration

Who cannot join

  • Presence of an open plantar ulceration
  • Presence of an untreated infection
  • Presence of osteomyelitis or gangrene

Trial locations and contacts

1 site in 1 country.

Deborah M. Wendland, PhD contact

6785476775

wendland_dm@mercer.edu

United States1 site, 1 recruiting
  • Piedmont Healthcare

    Atlanta, Georgia, 30309

    Teri Biven, DPT, 404-605-2743, Teri.Biven@piedmont.org

    Recruiting

Other trials in United States

About this study

Official title: The Effect of Self-directed Versus Therapist-directed Re-loading on Incidence of Ulcer Recurrence

This study is designed to evaluate if how people are told to return to walking after a skin injury affects whether or not they develop new (recurrence) skin breakdown on their feet. The people in this study will have diabetes and have a recently closed foot ulcer. About half will be specifically told how to return to walking and the other half will be told to return to walking slowly. How people naturally return to walking will also be established.

Read the detailed description

The purpose of this project is to determine the impact of Therapist-directed loading versus self-selected loading on ulcer occurrence and to establish natural loading behavior following diabetic foot ulcer closure.

Eligible participants will be randomized into a group given specific directions from a Therapist to return to walking (i.e. reloading skin following plantar ulceration closure) or a group encouraged to slowly return to walking (self-directed re-loading of the skin following plantar ulceration closure). Following randomization and instruction for re-loading according to group assignment, participants will be assessed every 6 months for walking behavior. Participants will be monitored for ulcer recurrence throughout. Participants will be followed for up to 18 months.

Being tested
Therapist-Directed Re-loading
Keywords
Diabetes, re-loading, ulcer recurrence
Medical subject headings
Diabetic Foot, Diabetes Mellitus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Therapist-Directed Re-loadingBehavioural

    Therapist will specifically direct participant to increase walking by 10% as measured at each of the activity monitoring assessments. In addition, the participant will be asked to monitor foot temperature to mitigate risk for breakdown.

Study groups in NCT04310137
Study groupRoleWhat they receive
Therapist-Directed Re-loadingExperimentalParticipants in this arm will be instructed to increase their activity by walking 10% more steps per day than the steps recorded in the most recent activity monitoring (i.e. StepWatch) measurement (e.g. 10% more than the initial monitoring values and 10% more than the second monitoring values once they are completed).
Receives: Behavioral: Therapist-Directed Re-loading
Self-Directed Re-loadingNo interventionParticipants in this arm will be instructed to slowly increase their walking.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of Ulcer Recurrence

    Assessment of incidence of any plantarr ulcer recurrence.

    Measured: Over up to 18 months of follow-up.

  2. Change in walking behavior (steps)

    Actual assessment of change in walking behavior will be assessed by number of steps.

    Measured: Assessed initially and every 6 months for 1 week for up to 18 months.

  3. Change in walking behavior (step timing)

    Actual assessment of change in walking behavior will be assessed by the timing of steps (how many steps in a given timeframe).

    Measured: Assessed initially and every 6 months for 1 week for up to 18 months.

Secondary outcomes (4)
  1. Exercise component of Summary of Diabetes Self-Care Activities Scale

    Questionnaire to assess exercise adherence. It is a report of the number of days that an individual participates in physical activity as well as specific exercise (2 questions). The higher the number, the more days of activity/exercise participation. The more days of participation, the better the investigators would expect health to be.

    Measured: Assessed initially and every 6 months for up to 18 months

  2. Bio-thesiometer

    Assesses vibration sense

    Measured: Assessed initially and every 6 months for up to 18 months

  3. Body Mass Index (BMI) and disease risk

    Weight and height will be combined to report BMI in kg/m^2.

    Measured: Assessed initially and every 6 months for up to 18 months

  4. Waist circumference

    Waist circumference (measured in cm) will be assessed for change over time.

    Measured: Assessed initially and every 6 months for up to 18 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Mar 2020
  2. Study start1 May 2021
  3. Primary completionDec 2023 (estimated)
  4. Study completionDec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized Controlled Trial
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04310137
Sponsor's protocol ID
H1908191
Status last verified
Oct 2021
First submitted
19 Feb 2020
Last updated
25 Oct 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified step data will be made available through a repository upon conclusion of the study and its dissemination.

Questions about this trial

What is this clinical trial studying?

A study testing Therapist-Directed Re-loading in people with Diabetic Foot Ulcer, run by Mercer University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 25 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Deborah M. Wendland, PhD (6785476775, wendland_dm@mercer.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence of Ulcer Recurrence (time frame: Over up to 18 months of follow-up.). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Oct 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in